{"analyses":[{"ciLowerLimit":"-1.134","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.999","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"0.799","groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"0.59","paramType":"Slope","paramValue":"0.433","statisticalComment":"The treatment effect was determined by testing the significance of the group by time interaction in GEE using a one degree-of-freedom (df) test.","statisticalMethod":"Generalized Estimating Equation (GEE)"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.2135","value":"57.4862"},{"groupId":"OG001","spread":"1.5767","value":"57.9322"}]}],"title":"BL"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.3859","value":"58.2839"},{"groupId":"OG001","spread":"1.29","value":"57.0924"}]}],"title":"6m"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.6786","value":"60.2116"},{"groupId":"OG001","spread":"1.4995","value":"59.4508"}]}],"title":"12m"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.6667","value":"57.7053"},{"groupId":"OG001","spread":"1.6168","value":"59.1793"}]}],"title":"18m"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.6478","value":"58.3315"},{"groupId":"OG001","spread":"1.8092","value":"59.1026"}]}],"title":"24m"}],"denoms":[{"counts":[{"groupId":"OG000","value":"75"},{"groupId":"OG001","value":"76"}],"units":"Participants"}],"description":"The weight of the left ventricle adjusted for body surface area (in g/m2). The mean is reported by arm at each timepoint with corresponding standard errors.","dispersionType":"Standard Error","groups":[{"description":"Patients received Carvedilol PO delivered at 6.25 mg twice daily (for a total dose of 12.5 mg per day) for 24 months.","id":"OG000","title":"Arm I (Carvedilol)"},{"description":"Patients received Placebo PO delivered at 6.25 mg twice daily (for a total dose of 12.5 mg per day) for 24 months.","id":"OG001","title":"Arm II (Placebo)"}],"paramType":"MEAN","populationDescription":"We excluded 31 participants who did not have a second time point assessment of echocardiography, resulting in 151 analyzable participants.","reportingStatus":"POSTED","timeFrame":"Baseline before treatment, 6 months, 12 months, 18 months, 24 months after treatment initiation","title":"Average Left Ventricular Mass","type":"SECONDARY","unitOfMeasure":"g/m^2"}